Gambia

Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia

The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.

Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.

The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.

In an unexpected incident, a dead man was found in the wheel bay of an airplane that flew from Gambia to Britain.

Maiden Pharmaceuticals Ltd will seek clearance to re-open its factory after agovernment laboratory found nothing wrong in samples taken from syrups that the World Health Organisation (WHO) had suspected of being linked to children' deaths in Gambia

The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.

Cough syrup samples of Maiden Pharmaceuticals have been found to be of standard quality, the government has told Parliament.

Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.

The committee to examine reports linking deaths of 66 children in The Gambia to four made-in-India cough syrups has observed the information shared by the World Health Organization is inadequate to determine aetiology.

Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.

The Haryana State Drugs Controller has given the company 7 days to respond to its show cause notice, barring which the manufacturing licence may be suspended or cancelled and further legal action taken.

India is testing samples of the cough syrups produced by Maiden Pharmaceuticals after the World Health Organisation said its products were linked to the deaths of dozens of children in the Gambia.

Gambia's President Adama Barrow on Friday said a surge in acute kidney injuries likely linked to a paracetamol syrup that killed dozens of children in past months was under control, with only two diagnoses in the last two weeks.

Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia

The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.

Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.

The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.

In an unexpected incident, a dead man was found in the wheel bay of an airplane that flew from Gambia to Britain.

Maiden Pharmaceuticals Ltd will seek clearance to re-open its factory after agovernment laboratory found nothing wrong in samples taken from syrups that the World Health Organisation (WHO) had suspected of being linked to children' deaths in Gambia

The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.

Cough syrup samples of Maiden Pharmaceuticals have been found to be of standard quality, the government has told Parliament.

Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.

The committee to examine reports linking deaths of 66 children in The Gambia to four made-in-India cough syrups has observed the information shared by the World Health Organization is inadequate to determine aetiology.

Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.

The Haryana State Drugs Controller has given the company 7 days to respond to its show cause notice, barring which the manufacturing licence may be suspended or cancelled and further legal action taken.

India is testing samples of the cough syrups produced by Maiden Pharmaceuticals after the World Health Organisation said its products were linked to the deaths of dozens of children in the Gambia.

Gambia's President Adama Barrow on Friday said a surge in acute kidney injuries likely linked to a paracetamol syrup that killed dozens of children in past months was under control, with only two diagnoses in the last two weeks.